Development And Characterization Of Aripipraziole Loaded Solid Lipid Microparticles
DOI:
https://doi.org/10.47750/pnr.2023.14.S01.10Abstract
The major challenge for brain targeting is to cross the blood-brain barrier (BBB) which limits several drugs and molecules to penetrate into the brain. In our research, we developed aripiprazole encapsulated solid lipid microparticles and characterized them according to standard methods. Microparticles were prepared by a hot melts microencapsulation approach byapplying various concentrations ration of Span 20, Span 80, Tween 20, and Tween 80. The drug release mechanism has been shown for every optimized formulation.
Downloads
Published
2023-01-01 — Updated on 2023-01-01
Issue
Section
Articles
How to Cite
Development And Characterization Of Aripipraziole Loaded Solid Lipid Microparticles. (2023). Journal of Pharmaceutical Negative Results, 78-98. https://doi.org/10.47750/pnr.2023.14.S01.10